Beyond LDL-C in assessing cardiovascular risk: ApoB or LDL-P?
Clinical Chemistry Podcast · Association for Diagnostics and Laboratory Medicine
June 4, 20138m 9s
Show Notes
Low-density lipoprotein cholesterol, a key cardiovascular biomarker is recommended by National Cholesterol Education Program, Adult Treatment Panel Guidelines, for assessing cardiovascular disease risk and for monitoring lipid-lowering therapy; however, some workers believe that the number of circulating LDL particles rather than LDL cholesterol is a strong indicator of future cardiovascular disease events.